These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30658612)

  • 1. Free testosterone value before radical prostatectomy is related to oncologic outcomes and post-operative erectile function.
    Li T; Sun X; Chen L
    BMC Cancer; 2019 Jan; 19(1):87. PubMed ID: 30658612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy.
    Porcaro AB; Caruso B; Terrin A; De Luyk N; Cacciamani G; Corsi P; Inverardi D; De Marchi D; Baldassarre R; Cerruto M; Ghimenton C; Brunelli M; Zecchini Antoniolli S; Petrozziello A; Artibani W
    Arch Ital Urol Androl; 2016 Mar; 88(1):17-22. PubMed ID: 27072171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low circulating free and bioavailable testosterone levels as predictors of high-grade tumors in patients undergoing radical prostatectomy for localized prostate cancer.
    Léon P; Seisen T; Cussenot O; Drouin SJ; Cattarino S; Compérat E; Renard-Penna R; Mozer P; Bitker MO; Rouprêt M
    Urol Oncol; 2015 Sep; 33(9):384.e21-7. PubMed ID: 25595576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between preoperative erectile dysfunction and prostate cancer features--an analysis from the Duke Prostate Center Database.
    Kimura M; Bañez LL; Gerber L; Qi J; Tsivian M; Freedland SJ; Satoh T; Polascik TJ; Baba S; Moul JW
    J Sex Med; 2012 Apr; 9(4):1174-81. PubMed ID: 22188861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigative clinical study on prostate cancer part IX and X: estradiol and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy.
    Porcaro AB; Ghimenton C; Petrozziello A; Sava T; Migliorini F; Romano M; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C
    Anticancer Res; 2012 Oct; 32(10):4523-32. PubMed ID: 23060581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative hormonal pattern in patients undergoing radical prostatectomy due to prostate cancer.
    García-Cruz E; Castañeda-Argáiz R; Carrión A; Alcover J; Sallent A; Leibar-Tamayo A; Romero-Otero J; Alcaraz A;
    Actas Urol Esp; 2013 May; 37(5):280-5. PubMed ID: 23246101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of pretreatment serum total testosterone measurements with pathology-detected Gleason score cancer.
    Porcaro AB; Petrozziello A; Ghimenton C; Migliorini F; Sava T; Caruso B; Romano M; Cavalleri S; Artibani W
    Urol Int; 2014; 93(3):269-78. PubMed ID: 24334919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative low serum testosterone is associated with high-grade prostate cancer and an increased Gleason score upgrading.
    Pichon A; Neuzillet Y; Botto H; Raynaud JP; Radulescu C; Molinié V; Herve JM; Lebret T
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):382-7. PubMed ID: 26439747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative erectile function is an independent predictor for decision to spare cavernous nerves during radical prostatectomy.
    Stember DS; Nelson CJ; Mulhall JP
    J Sex Med; 2013 Aug; 10(8):2101-7. PubMed ID: 23679104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective comprehensive assessment of sexual function after retropubic non nerve sparing radical prostatectomy for localized prostate cancer.
    Trinchieri A; Nicola M; Masini F; Mangiarotti B
    Arch Ital Urol Androl; 2005 Dec; 77(4):219-23. PubMed ID: 16444937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum total testosterone is a significant preoperative variable independently contributing to separating the prostate cancer population into prostatectomy Gleason score groups.
    Porcaro AB; Petrozziello A; Ghimenton C; Migliorini F; Sava T; Caruso B; Cocco C; Romano M; Cavalleri S; Artibani W
    Urol Int; 2013; 91(1):55-61. PubMed ID: 23751412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Testosterone Preoperative Plasma Levels Independently Predict Biopsy Gleason Score Upgrading in Men with Prostate Cancer Undergoing Radical Prostatectomy.
    Porcaro AB; Petroziello A; Brunelli M; De Luyk N; Cacciamani G; Corsi P; Sebben M; Tafuri A; Tamanini I; Caruso B; Ghimenton C; Monaco C; Artibani W
    Urol Int; 2016; 96(4):470-8. PubMed ID: 26845458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European population.
    Becker A; Tennstedt P; Hansen J; Trinh QD; Kluth L; Atassi N; Schlomm T; Salomon G; Haese A; Budaeus L; Michl U; Heinzer H; Huland H; Graefen M; Steuber T
    BJU Int; 2014 Jul; 114(1):38-45. PubMed ID: 24053677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment.
    Loeb S; Folkvaljon Y; Robinson D; Schlomm T; Garmo H; Stattin P
    Eur Urol; 2016 Nov; 70(5):824-828. PubMed ID: 26743040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative erectile function and the pathologic features of prostate cancer.
    Jeong CW; Lee S; Jeong SJ; Hong SK; Byun SS; Lee SE
    Int Braz J Urol; 2015; 41(2):265-73. PubMed ID: 26005967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of Baseline Erectile Function in Men Following Radical Prostatectomy for High-Risk Prostate Cancer: A Prospective Analysis Using Validated Measures.
    Sridhar AN; Cathcart PJ; Yap T; Hines J; Nathan S; Briggs TP; Kelly JD; Minhas S
    J Sex Med; 2016 Mar; 13(3):435-43. PubMed ID: 26944466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer.
    Schnoeller T; Jentzmik F; Rinnab L; Cronauer MV; Damjanoski I; Zengerling F; Ghazal AA; Schrader M; Schrader AJ
    World J Urol; 2013 Apr; 31(2):253-9. PubMed ID: 22763628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Calculated Free Testosterone Overcome Total Testosterone in Protecting From Sexual Symptom Impairment? Findings of a Cross-Sectional Study.
    Boeri L; Capogrosso P; Ventimiglia E; Cazzaniga W; Pederzoli F; Moretti D; Dehò F; Montanari E; Montorsi F; Salonia A
    J Sex Med; 2017 Dec; 14(12):1549-1557. PubMed ID: 29198510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of testosterone as a predictor of tumor aggressiveness in patients with prostate cancer.
    Cabral PH; Iwamoto MW; Fanni VS; Barros Lda R; Cardoso SN; Mello LF; Glina S
    Int Braz J Urol; 2013; 39(2):173-81. PubMed ID: 23683664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.